updates in lung cancer: neoadjuvant immunotherapy and targeted therapies
Published 6 months ago • 310 plays • Length 6:57Download video MP4
Download video MP3
Similar videos
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
1:25
neoadjuvant therapy is taking off in lung cancer
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
1:16
will neoadjuvant targeted therapies play a role in nsclc?
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
3:25
moving immunotherapy and targeted therapies to the frontline setting
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer
-
1:51
future directions for neoadjuvant immunotherapy in lung cancer
-
3:27
trial updates in neoadjuvant adjuvant therapies for early-stage nsclc
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
1:02
early intervention neoadjuvant immunotherapy in lung cancer
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
51:42
updates in the management of lung cancer
-
4:40
tki neoadjuvant: is complete pathological response possible?- targeted therapies in lung cancer 2023
-
28:29
medical oncology updates for lung cancer
-
1:44
updates in early-stage lung cancer: 2023 west oncology
-
11:16
8 in 8: update on immunotherapy for resectable lung cancer